Definium Therapeutics (DFTX) Q2 2026 Earnings

May 7Confirmed
Q4 2025
Q2 2026
-0.78
-0.68
-0.59
-0.49

Details

Expected EPS
-0.492129
Actual EPS
-0.71
Surprise EPS
-0.22
Surprise Percent
-44.27%

Description

⁨Definium Therapeutics⁩ (⁦DFTX⁩) has reported earnings of ⁦-0.71⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts